Recombinant antibody technology
Recombinant antibody technology has addressed many problems associated with hybridoma-based platforms, opening the door to a new class of biologics. Today, this technology continues to contribute to the discovery and development of new antibody-based therapeutics and improve the performance of other biological modalities.
In this article, Sino Biological explores the advantages of recombinant antibody engineering, recombinant antibodies’ distinct requirements for specific applications and their significant potential in future therapeutic development.
Recombinant antibody technology - to BioTechniques
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
